An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed ...

New inhaled COVID-19 vaccine by McMaster enters phase-2 trials in Canada. The vaccine aims to provide stronger, needle-free ...

UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday at an international conference.

The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis that has claimed more than seven ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine. The ...

For participants in clinical trials, the answer is a hard no. The Trump administration's decision to end funding for the U.S.

At the fifth anniversary of the COVID-19 pandemic, UPMC and Pitt Student Health Services reveal the lasting changes that the ...

A new study reveals differences in survival rates for COVID-19 pneumonia patients treated with ECMO compared to non-COVID-19 pneumonia patients.

A drug called ensitrelvir can help prevent Covid-19 in people who have been exposed within households. This finding comes from an international clinical trial a UVA School of Medicine professor helped ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

A major meta-analysis of 1.3 million patients confirms remdesivir improves COVID-19 survival. But are treatment guidelines keeping up with the evidence?